Abstract
We used single-strand conformation polymorphism (SSCP) analysis of p53 exons 4–8 to screen for possible mutations in 25 pediatric de novo leukemias with translocations of the MLL gene at chromosome band 11q23. Of the 25 patients, 21 were infants. Fifteen cases were acute myeloid leukemia (AML), eight were acute lymphoblastic leukemia (ALL), and two cases were biphenotypic. Nineteen cases were studied at diagnosis and six at time of relapse. p53 mutations were absent in all 19 cases studied at the time of diagnosis. The only mutation was a TGC→TTC transversion (cys→phe) at codon 141 in exon 5 in a case of infant ALL at relapse that occurred by subclone evolution after MLL gene translocation. We previously showed that p53 mutations are also absent in pediatric treatment-related leukemias with MLL gene translocations. The absence of p53 mutations at initial transformation may suggest that the anti-apoptotic effect of mutant p53 is not important in leukemias with MLL gene translocations. Alternatively, exogenous DNA damage may be the common feature in treatment-related and de novo cases. Since MLL gene translocations may occur through DNA repair and wild-type p53 is central to DNA repair, the absence of p53 mutations raises the possibility that wild-type p53, not mutant p53, may be important in the genesis of leukemias with these translocations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Megonigal, M., Rappaport, E., Nowell, P. et al. Potential role for wild-type p53 in leukemias with MLL gene translocations. Oncogene 16, 1351–1356 (1998). https://doi.org/10.1038/sj.onc.1201637
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201637
Keywords
This article is cited by
-
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
Nature Communications (2019)
-
Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study
Leukemia (2005)
-
Detection of p53 gene mutation in plasma of patients with gastric cancer
Chinese Journal of Cancer Research (2004)
-
Transcription factor fusions in acute leukemia: variations on a theme
Oncogene (2002)